Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial

Gynecologic Oncology

Volumn 61, Issue 1, 1996, Pages 3-10

  Curtin, John P ^a   Hoskins, William J ^a   Venkatraman, Ennapadam S ^a   Almadrones, Lois ^a   Podratz, Karl C ^b   Long, Harry ^b   Teneriello, Michael ^c   Averette, Hervy ^d   Sevin, Bernd Uwe ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0029923154     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0087     Document Type: Article

References (21)

1. Artman, L. E., Hoskins, W. J., Bibro, M. C., Heller, P. B., Weiser, E. B., Barnhill, D. R., and Park, R. C. Radical hysterectomy and pelvic lymphadenectomy for Stage IB carcinoma of the cervix: 21 years' experience, Gynecol. Oncol. 28, 8-13 (1987).
2. Monaghan, J. M., Ireland, D., Mor-Yosef, S., Pearson, S. E., Lopes, A., and Sinha, D. P. Role of centralization of surgery in Stage IB carcinoma of the cervix: A review of 498 cases, Gynecol. Oncol. 37, 206-209 (1990).
3. Hopkins, M. P., and Morley, G. W. Radical hysterectomy versus radiation therapy for Stage IB squamous cell cancer of the cervix, Cancer 68, 272-277 (1991).
4. Kamura, T., Tsukamoto, N., Tsuruchi, N., Saito, T., Masuyama, T., Akazawa, K., and Nakano, H. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy, Cancer 69, 181-186 (1992).
5. Burke, T. W., Hoskins, W. J., Heller, P. B., Shen, M. C., Weiser, E. B., and Park, R. C. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical cancer, Obstet. Gynecol. 69, 382-385 (1987).
6. Fuller, A. F., Elliott, N., Kosloff, C., Hoskins, W. J., and Lewis, J. L., Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix, Gynecol. Oncol. 33, 34-39 (1989).
7. Delgado, G., Bundy, B., Zaino, R., Sevin, B.-U., Creasman, W. T., and Major, F. Prospective surgical-pathological study of disease-free interval in patients with Stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study, Gynecol. Oncol. 38, 352-357 (1990).
8. Kinney, W. K., Alvarez, R. D., Reid, G. C., Schray, M. F., Soong, S.-J., Morley, G. W., Podratz, K. C., and Shingleton, H. M. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study, Gynecol. Oncol. 34, 258-262 (1989).
9. Soisson, A. P., Soper, J. T., Clarke-Pearson, D. L., Berchuk, A., Montana, G., and Creasman, W. T. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer, Gynecol. Oncol. 37, 390-395 (1990).
10. Larson, D. M., Stringer, C. A., Copeland, L. J., Gershenson, D. M., Malone, J. M., and Rutledge, F. N. Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy: Role of adjuvant radiotherapy, Obstet. Gynecol. 69, 378-381 (1987).
11. Monk, B. J., Cha, D.-S., Walker, J. L., Burger, R. A., Ramsinghani, N. S., Manetta, A., DiSaia, P. J., and Berman, M. L. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma, Gynecol. Oncol. 54, 4-9 (1994).
12. Wertheim, M. S., Hakes, T. B., Daghestani, A. N., Nori, D., Smith, D. S., and Lewis, J. L., Jr. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy, J. Clin. Oncol. 3, 912-916 (1985).
13. Lewis, J. L., Jr., Nori, D., Hoskins, W., Jones, W., Markman, M., Reichman, B., Rubin, S., Almadrones, L., and Hakes, T. Adjuvant cisplatin/bleomycin and radiation in patients at high risk of recurrence after radical surgery for stage IB/IIA cervix carcinoma, Proc. Int. Gynecol. Cancer Soc. (1989). [Abstract]
14. Sardi, J., Sananes, C., Giaroli, A., Bayo, J., Rueda, N. G., Vighi, S., Guardado, N., Paniceres, G., Snaidas, L., Vico, C., and DiPaola, G. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix, Gynecol. Oncol. 49, 156-165 (1993).
15. Panici, P. B., Greggi, S., Scambia, G., Ragusa, G., Baiocchi, G., Battaglia, F., Coronetta, F., and Mancuso, S. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report, Gynecol. Oncol. 41, 212-216 (1991).
16. Sivanesaratnam, V., and Jayalakshmi, P. Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer, Cancer 64, 798-800 (1989).
17. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecological cancer (F. Pettersson, Ed.), Panorama Press AB, Stockholm, Vol. 21 (1991).
18. Kaplan, E., and Meier, P. Non-parametric estimation for incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
19. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., and Smith, P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br. J. Cancer 35, 1-39 (1977).
20. Killackey, M. A., Boardman, L., and Carroll, D. S. Adjuvant chemotherapy and radiation in patients with poor prognostic stage IB/IIA cervical cancer, Gynecol. Oncol. 49, 377-379 (1993).
21. Tattersall, M. H. N., Ramirez, C., and Coppleson, M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage IB-IIA cervical cancer patients with pelvic lymph node metastases, Gynecol. Oncol. 46, 176-181 (1992).